fda ban semaglutide New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal on mass compounding of "semaglutide" takes effect Some people are overdosing on

This article explains the most common causes, how clinicians evaluate bleeding, when to seek urgent...

In consideration of the enhanced metabolic parameters observed with GLP-1 RAs, they may be recommended as useful hypoglycaemic medication for the management of T2DM with OSA

On March 20, 2023, the patent for semaglutide expired in India, bringing nearly 40 affordable generics to market

Why wont my insurance cover weight loss medications? Despite their health benefits, many insurance companies are reluctant to cover effective obesity treatments like GLP-1 meds.

PlexusDx explains the science and what to expect

In this episode of Let's Talk About Health, we explore the growing interest in GLP-1 medicationsoriginally used for type 2 diabetes but now popular for their impact on weight loss